HISTORY AND PROSPECTS IN CALCIUM-ANTAGONIST RESEARCH

[11] FLECKENSTEIN A, 1983, EXPT FACTS THERAPEUT

[12] FLECKENSTEIN A, 1967, BIOCH APPLICATA 1, V14, P323

[13] FLECKENSTEIN A, 1970, CALCIUM HEART, P135

[14] FLECKENSTEINGRU.G, 1984, RECENT ASPECTS CALCI, P29

[15] FLECKENSTEINGRU.G, 1982, CALCIUM MODULATORS, P141

[16] FLECKENSTEINGRU.G, 1985, BAYER S, V9, P309

[17] FLECKENSTEINGRU.G, 1985, TRENDS PHARMACOL SCI, V6, P235

[18] FLECKENSTEINGRU.G, 1985, CALCIUM BIOL SYSTEMS, P431

[19] FLECKENSTEINGRUN G, 1984, TRENDS PHARM SCI, V5

[20] GLECKENSTEINGRU.G, 1985, ICSU S SERIES, V6, P235

[11] FLECKENSTEIN A, 1983, EXPT FACTS THERAPEUT

[12] FLECKENSTEIN A, 1967, BIOCH APPLICATA 1, V14, P323

[13] FLECKENSTEIN A, 1970, CALCIUM HEART, P135

[14] FLECKENSTEINGRU.G, 1984, RECENT ASPECTS CALCI, P29

[15] FLECKENSTEINGRU.G, 1982, CALCIUM MODULATORS, P141

[16] FLECKENSTEINGRU.G, 1985, BAYER S, V9, P309

[17] FLECKENSTEINGRU.G, 1985, TRENDS PHARMACOL SCI, V6, P235

[18] FLECKENSTEINGRU.G, 1985, CALCIUM BIOL SYSTEMS, P431

[19] FLECKENSTEINGRUN G, 1984, TRENDS PHARM SCI, V5

[20] GLECKENSTEINGRU.G, 1985, ICSU S SERIES, V6, P235